<DOC>
	<DOCNO>NCT00010400</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine induction durable remission patient life-threatening systemic lupus erythematosus antiphospholipid antibody syndrome treat cyclophosphamide . II . Determine toxicity drug patient .</brief_summary>
	<brief_title>Pilot Study Cyclophosphamide Patients With Life-Threatening Systemic Lupus Erythematosus Antiphospholipid Antibody Syndrome</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive cyclophosphamide IV day 1-4 filgrastim ( G-CSF ) begin day 10 continue blood count recover . Patients follow monthly 6 month , every 3 month thereafter .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Antiphospholipid Syndrome</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Antiphospholipid</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis lifethreatening systemic lupus erythematosus ( SLE ) ; must show least 4 American College Rheumatology criterion SLE ; must severe organ damage 1 organ ; must 1 follow indication ongoing disease activity : disease activity score ( SLEDAI ) least 4 , hospitalization disease activity within 12 month , lifethreatening disease capture SLEDAI OR Diagnosis antiphospholipid antibody syndrome Hughes criterion ; must show severity ongoing symptom sign hypercoagulability spite warfarin therapy Patient Characteristics Hepatic : Bilirubin great 2.0 mg/dL ; transaminases great 2.0 time normal Renal : Creatinine great 3.0 mg/dL Cardiovascular : Ejection fraction least 45 % Pulmonary : FVC , FEV1 , DLCO least 50 % predict Other : Not preterminal moribund ; pregnant nursing ; fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>antiphospholipid antibody syndrome</keyword>
	<keyword>arthritis &amp; connective tissue disease</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>systemic lupus erythematosus</keyword>
</DOC>